Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-05-01 | Our Nominating and Governance Committee consists of four directors: Dr. Gregory Brown (Chair), Dr. Azab, Ms. Flowers and Dr. Ruoslahti. ... The following table sets forth information on all compensation to Lisata's directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2022. ... Mohammad Azab, M.D., M.B.A. $14,380 Fees Earned in Cash, $120,000 Stock Awards, $134,380 Total Compensation. |
| 2024-04-29 | Mohammad Azab, M.D., M.B.A. was appointed to our board of directors in September 2022. Dr. Azab is a leader in clinical and regulatory development of biopharmaceutical drugs with particular expertise in oncology drug development. |
Data sourced from SEC filings. Last updated: 2025-08-30